Label at a glance#

ProductBISACODYL

Active ingredientBISACODYL

Label structure9 sections

Indications and uses

relieves occasional constipation. this product generally produces a bowel movement in 15 minutes to 1 hour.

Dosage and administration

tear off one suppository from the strip. tear and peel the wrapper in downward motion. continue tearing downward to almost the full length of the suppository (see illustration at the right) gently remove the suppository from the wrapper. lie on your side and push suppository. with pointed end first, high into the rectum so it will not slip out retain it for 15 to 20 minutes. Do not exceed recommended dose if suppo...

Storage and handling

store at temperatures below 30'C (86'F)

Label contents#

Full prescribing information#

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

Active ingredient (in each suppository) Purpose

Bisacodyl USP 10 mg ................................ Stimulant laxative

Uses

OTC - PURPOSE SECTION

relieves occasional constipation.

this product generally produces a bowel movement in 15 minutes to 1 hour.

Directions

INDICATIONS & USAGE SECTION

tear off one suppository from the strip.
tear and peel the wrapper in downward motion.
continue tearing downward to almost the full length of the suppository (see illustration at the right)
gently remove the suppository from the wrapper.
lie on your side and push suppository. with pointed end first, high into the rectum so it will not slip out
retain it for 15 to 20 minutes.
Do not exceed recommended dose
if suppository seems soft, place in refrigerator for a short time before use
Adults and children 12 years and over 1 suppository once daily.
Children under 12 years Ask a doctor.

DOSAGE & ADMINISTRATION SECTION

Adults and children 12 years and over 1 suppository once daily.
Children under 12 years Ask a doctor.

WARNINGS

WARNINGS SECTION

For rectal use only.

Do not use when abdominal pain, nausea, or vomiting are present.

Ask a doctor before use if you have a sudden change in bowel habits that lasts over a period of 2 weeks.

When using this product you may experience. rectal burning. mild cramps.abdominal discomfort. faintness.

stop use and ask a doctor if you have rectal bleeding. you fill to have a bowel movement after using a laxative. These may be signs of a serious condition.

you need to use a laxative for more than one week.

if pregnant or breast-feeding, ask a health professional before use.

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

hydrogenated vegetable oil

STORAGE

STORAGE AND HANDLING SECTION

store at temperatures below 30'C (86'F)

KEEP OUT OF REACH OF CHILDREN

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a poison control center right away.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Label of BoxEnter section text here

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
198509	bisacodyl 10 MG Rectal Suppository	PSN	3
198509	bisacodyl 10 MG Rectal Suppository	SCD	3

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
BISACODYL Pharmacologic Class Indexing	1	Indexing - Pharmacologic Class	20101101

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
54162-006-12	2019-11-13	C162847	48780-1	97449f38-ce24-f6ea-e053-dbdaa90aa703	Bisacodyl Suppositories

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
54162-006-12	BISACODYL	2 g in 1 BOX, UNIT-DOSE	SUPPOSITORY	2		3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
54162-006	BISACODYL SUPPOSITORY [GERITREX CORP.]	3	Legacy NDC, 1 package rows	20120413_933a409e-09de-42f4-ab93-f47d05ced4b8.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
54162-006-01	EA - Each	54162-006	aa1f32e0-c15c-4bc0-8db5-553c44cbffef	1	2012-07-24
54162-006-12	EA - Each	54162-006	5606a3c7-1ef7-461c-9687-9a86ccdc61a9	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
BISACODYL	ACTIVE INGREDIENT	10X0709Y6I	3
BISACODYL	ACTIVE MOIETY	10X0709Y6I	3
HYDROGENATED SOYBEAN OIL	INACTIVE INGREDIENT	A2M91M918C	3

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 2 matching rows.

BISACODYL
HYDROGENATED SOYBEAN OIL

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
54162-006	54162-006-12

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
BISACODYL	10X0709Y6I	ACTIB
HYDROGENATED SOYBEAN OIL	A2M91M918C	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 4 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
HYDROGENATED SOYBEAN OIL	HYDROGENATED SOYBEAN OIL	A2M91M918C	TABLET, COATED / ORAL	3 mg		Exact identifier — unii candidate 4 equally ranked IID candidates
HYDROGENATED SOYBEAN OIL	HYDROGENATED SOYBEAN OIL	A2M91M918C	TABLET, EXTENDED RELEASE / ORAL		96 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
HYDROGENATED SOYBEAN OIL	HYDROGENATED SOYBEAN OIL	A2M91M918C	CAPSULE / ORAL		95 mg	Exact identifier — unii candidate 4 equally ranked IID candidates
HYDROGENATED SOYBEAN OIL	HYDROGENATED SOYBEAN OIL	A2M91M918C	TABLET / ORAL	13.5 mg		Exact identifier — unii candidate 4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
63a99d4b-5b19-41c8-88d8-6582011e4ec7			933a409e-09de-42f4-ab93-f47d05ced4b8	2012-02-23	Warnings	Exact identifier spl id: 63a99d4b-5b19-41c8-88d8-6582011e4ec7 spl set id: 933a409e-09de-42f4-ab93-f47d05ced4b8

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.